author-photo

Haiko J. Bloemendal

Utrecht University

45

Papers

795

Citations

Citation Trend

Filter By

Papers (28) Sort By

Journal Conference Others

642TiP Phase II CA184-585 (INSPIRE) trial of ipilimumab with nivolumab for molecular-selected patients with castration-resistant prostate cancer

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1594P Harmonising patient-access programmes

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Update on the Drug Rediscovery Protocol: Expanded use of existing anticancer drugs in patients with a known molecular profile.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract CT145: Repeated radium-223-chloride versus rhenium-188-HEDP in patients with metastatic castration-resistant prostate cancer: RaRe study

2019 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (0)
The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies

2019 Nature Genetics
Show All
- Source
- Cite
- Save
Citations (103)
The predictive value of cumulative toxicity for quality of life in patients with metastatic colorectal cancer during first-line palliative chemotherapy

2018 Cancer management and research
Show All
- Source
- Cite
- Save
Citations (9)
862TiPReCab II: A phase II trial of Cabazitaxel +/- Rhenium -188-HEDP in patients with metastatic castration resistant prostate cancer who progressed on or after a docetaxel containing treatment

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Phase 1 Trial of Cabazitaxel Combined With 188Re–Hydroxyethylidene Diphosphonate in Patients With Metastatic Castration-Resistant Prostate Cancer Who Progressed on or After a Docetaxel-Containing Treatment: The ReCab Trial

2017 Clinical Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (2)
Cost of illness of metastatic prostate cancer: a perspective of costs for new treatment options in The Netherlands

2017 Journal of Comparative Effectiveness Research
Show All
- Source
- Cite
- Save
Citations (1)
Towards better dose individualisation: metabolic phenotyping to predict cabazitaxel pharmacokinetics in men with prostate cancer

2017 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (5)